Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-masked and Placebo-controlled Study Evaluating the Efficacy and Safety of SI-614 Ophthalmic Solution in Patients With Dry Eye

NCT05411367 is registered in ClinicalTrials.gov with Seikagaku Corporation as lead sponsor.

NCT NCT05411367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05411367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-masked and Placebo-controlled Study Evaluating the Efficacy and Safety of SI-614 Ophthalmic Solution in Patients With Dry Eye
Lead sponsor
Seikagaku Corporation
Phase
Phase 3
Overall status
Completed
Start date
July 28, 2022
Completion date
April 27, 2023
Enrollment
232 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease